BartualS. G., SeifertH., HipplerC., LuzonM. A., WisplinghoffH., Rodríguez-ValeraF.2005; Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43:4382–4390 [View Article][PubMed]
CLSI2009; Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M07-A8 , 8th edn. Wayne, PA: Clinical and Laboratory Standards Institute;
HeC., XieY., ZhangL., KangM., TaoC., ChenZ., LuX., GuoL., XiaoY.other authors2011; Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit. J Med Microbiol 60:337–341 [View Article][PubMed]
HoranT. C., AndrusM., DudeckM. A.2008; CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–332 [View Article][PubMed]
KallenA. J., HidronA. I., PatelJ., SrinivasanA.2010; Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006–2008. Infect Control Hosp Epidemiol 31:528–531 [View Article][PubMed]
KhanF. Y., AbukhattabM., BaagerK.2012; Nosocomial postneurosurgical Acinetobacter baumannii meningitis: a retrospective study of six cases admitted to Hamad General Hospital, Qatar. J Hosp Infect 80:176–179 [View Article][PubMed]
ManageiroV., Jones-DiasD., FerreiraE., LouroD., CanicaM.2012; Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118. Int J Antimicrob Agents 40:398–403 [View Article][PubMed]